Metraipolis › archive › dc_a228caa3209e
Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study — Europe PMC PMID:29159517
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/29159517
- DOI
- 10.1007/s12282-017-0815-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-10T00:27:54.731Z
- SHA-256 of the archived text
b26960296bbaaa7d982a897e21eead59a163af193538ee5bc494a71fb6680f3a- Stable URL of this page
https://metraipolis.com/documento/dc_a228caa3209e
How to cite
Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study — Europe PMC PMID:29159517 — Europe PMC (en), https://europepmc.org/article/MED/29159517 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a228caa3209e (Metraipolis archive dc_a228caa3209e, sha256 b26960296bbaaa7d982a897e21eead59a163af193538ee5bc494a71fb6680f3a)
BibTeX
@misc{dca228caa3209e,
title = {Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study — Europe PMC PMID:29159517},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/29159517},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a228caa3209e; sha256 b26960296bbaaa7d982a897e21eead59a163af193538ee5bc494a71fb6680f3a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/29159517. Agents can read the archived copy with the MCP tool read_document.